LAFAYETTE PHARMACAL INC. – Trademark Portfolio

Entity Type: 03

LAFAYETTE PHARMACAL INC. holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 19 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SITZMARKS. The owner is based in LAFAYETTE, IN.

15TH AND BALL STREETS

LAFAYETTE, IN

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

LAFAYETTE PHARMACAL INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (19 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does LAFAYETTE PHARMACAL INC. have?

LAFAYETTE PHARMACAL INC. has 20 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 17 cancelled.

What trademark classes does LAFAYETTE PHARMACAL INC. file in?

LAFAYETTE PHARMACAL INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are LAFAYETTE PHARMACAL INC.'s most well-known trademarks?

LAFAYETTE PHARMACAL INC.'s registered trademark portfolio includes well-known marks such as SITZMARKS. These are among 1 currently registered trademark in the portfolio.

What is LAFAYETTE PHARMACAL INC.'s trademark registration success rate?

LAFAYETTE PHARMACAL INC. has a 5% trademark registration rate, with 1 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.